Compass Pathways

🏢 Neurotechnology

Overview

Compass Pathways is a biopharmaceutical company developing innovative treatments for mental health disorders, with a focus on psilocybin-assisted therapies for treatment-resistant conditions. The company combines neuroscience research with clinical development to advance novel therapeutic pathways in neuropsychiatry.

More in Neurotechnology

Blackrock Neurotech

COGNOTICA

Deep Sleep Technologies

Flow Neuroscience

g.tec medical engineering GmbH - NEVER STOP RECORDING

INBRAIN Neuroelectronics

Latest industry news

FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD

2026-09-03 · Policy

Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%

2026-09-02 · Industry

Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream

2026-09-01 · Industry

FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface

2026-08-31 · Policy

Company details

Is this your company?

Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.

Claim & upgrade listing

Advertise

Reach neurotech professionals

Newsletter sponsorships, featured listings, and sponsored articles.

View packages →